Results 81 to 90 of about 17,718 (201)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes

, 2016
Faraz Razi, Adnaan Haq, Prabhu Tonne, Maharatnam Logendran   +3 more
openalex   +2 more sources

Efficacy of intravitreal injection of Ranibizumab combined with macular grid photocoagulation for diabetic macular edema

, 2020
Pingping Ma, Li-Yin Liang, Qingyang Liu, Jinbiao Zheng   +3 more
openalex   +2 more sources

Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab [PDF]

, 2015
Nathalie Massamba, Ali Dirani, Juliette Knoeri, B Pasquier, April Ingram, G. Soubrane   +5 more
openalex   +1 more source

Intravitreal Conbercept or Ranibizumab for myopic choroidal neovascularization

, 2022
Caiyun Zhang, Chu-Lan Li, Jianbo Mao, Li-Jun Shen   +3 more
openalex   +2 more sources

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six‐month results of a prospective randomized clinical trial [PDF]

, 2014
Amelie Pielen, Alireza Mirshahi, Nicolas Feltgen, Katrin Lorenz, Christina A. Korb, Bernd Junker, Caroline Schaefer, Isabella Zwiener, Lars‐Olof Hattenbach, the RABAMES Study Group   +9 more
openalex   +1 more source

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting

Clinical Ophthalmology, 2012
Angela M Carneiro,1,2 Luis S Mendonça,1 Manuel S Falcão,1,2 Sofia L Fonseca,1 Elisete M Brandão,1 Fernando M Falcão-Reis1,21Department of Ophthalmology of Hospital de São João, Porto ...
Carneiro AM, Mendonça LS, Falcão MS, Fonseca SL, Brandão EM, Falcão-Reis FM   +5 more
doaj  

Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy

, 2021
Tessy Xavier, Swetha Pallikara, Neha Saji, Natasha Radhakrishnan, Krishnakumar N. Menon, Gopal S Pillai   +5 more
openalex   +1 more source

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance

Clinical Ophthalmology, 2018
Ali Dirani, Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland Purpose: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after ...
Dirani A, Mantel I
doaj  

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

Clinical Ophthalmology, 2013
Michael A Singer,1 Steven R Cohen,2 Sylvia L Groth,3 Salman Porbandarwalla21Medical Center Ophthalmology Associates (MCOA), San Antonio, Texas, USA; 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio ...
Singer MA, Cohen SR, Groth SL, Porbandarwalla S   +3 more
doaj  

Treatment for neovascular glaucoma with Ranibizumab and trabeculectomy

, 2019
Jian Zhang, Yan-Xiu Qi, Xing-Jie Su, Yuqing Wang   +3 more
openalex   +2 more sources